IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 93 filers reported holding IMMUNOMEDICS INC in Q2 2015. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,321,000 | +15.1% | 360,037 | +2.0% | 0.00% | +100.0% |
Q3 2016 | $1,148,000 | +41.7% | 353,111 | +1.1% | 0.00% | 0.0% |
Q2 2016 | $810,000 | -6.1% | 349,301 | +1.2% | 0.00% | 0.0% |
Q1 2016 | $863,000 | -16.9% | 345,085 | +2.0% | 0.00% | 0.0% |
Q4 2015 | $1,039,000 | +80.1% | 338,296 | +0.9% | 0.00% | 0.0% |
Q3 2015 | $577,000 | -58.5% | 335,194 | -2.2% | 0.00% | -50.0% |
Q2 2015 | $1,391,000 | +48.3% | 342,608 | +39.8% | 0.00% | +100.0% |
Q1 2015 | $938,000 | -19.4% | 244,996 | +1.0% | 0.00% | -50.0% |
Q4 2014 | $1,164,000 | +26.7% | 242,468 | -1.8% | 0.00% | +100.0% |
Q3 2014 | $919,000 | +4.3% | 247,022 | +2.3% | 0.00% | 0.0% |
Q2 2014 | $881,000 | +1.1% | 241,498 | +16.7% | 0.00% | 0.0% |
Q1 2014 | $871,000 | -8.3% | 206,966 | +0.2% | 0.00% | 0.0% |
Q4 2013 | $950,000 | -27.2% | 206,490 | -1.9% | 0.00% | -50.0% |
Q3 2013 | $1,305,000 | +20.7% | 210,540 | +5.9% | 0.00% | 0.0% |
Q2 2013 | $1,081,000 | – | 198,760 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,711,067 | $2,943,000 | 1.70% |
J.P. Turner & Co Capital Mnagement, LLC | 248,625 | $428,000 | 0.44% |
Orbimed Advisors | 3,323,000 | $5,716,000 | 0.06% |
BALYASNY ASSET MANAGEMENT L.P. | 2,004,078 | $3,447,000 | 0.02% |
WOLVERINE ASSET MANAGEMENT LLC | 5,870 | $1,018,000 | 0.02% |
SIGNET FINANCIAL MANAGEMENT, LLC | 44,675 | $77,000 | 0.02% |
SVB WEALTH LLC | 195,000 | $335,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 288,900 | $497,000 | 0.01% |
J.P. Turner & Co Capital Mnagement, LLC | 153,900 | $8,000 | 0.01% |
BALYASNY ASSET MANAGEMENT L.P. | 640,400 | $1,101,000 | 0.01% |